FDA Inspection 1271145 — Bioggio Pharma Manufacture SA

Bioggio Pharma Manufacture SA — FEI 3009385425

The FDA completed an inspection of Bioggio Pharma Manufacture SA on May 23, 2025 in Bioggio. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
May 23, 2025
Fiscal Year
2025
Product Type
Food/Cosmetics
Project Area
Foodborne Biological Hazards
Location
Bioggio (Switzerland)

Citations

IDCFRDescription
1570221 CFR 111.320(b)Examination, testing; scientifically valid
1586321 CFR 111.75(a)(2)(ii)(B)Component - certificate of analysis
2284321 CFR 111.70(b)Specifications - components
2284721 CFR 111.70(e)Specifications - finished dietary supplement
447021 CFR 108.25(c)(2)Process filing

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.